Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$499.74 -9.01 (-1.77%)
At close: Oct 16, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Cash from Operations (2009 - 2026)

Updated

Vertex Pharmaceuticals' Cash from Operations was $1.13 billion in Q2 2026, up 4.9% from $1.07 billion a year earlier but down 21.2% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Cash from Operations (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vertex Pharmaceuticals' Cash from Operations was $4.29 billion through Jun 30, 2026, up 11.6% year-over-year; for FY2025, it was $3.63 billion.

  • Cash from Operations shows a five-year compound annual growth rate of 2.2% (FY2020 to FY2025).
  • In earlier years, Cash from Operations was -$492.6 million in FY2024, $3.54 billion in FY2023 (-14.3%), $4.13 billion in FY2022 (+56.2%) and $2.64 billion in FY2021 (-18.7%).
  • Quarterly Cash from Operations has moved between -$3.75 billion (Q2 2024) and $1.43 billion (Q1 2026) over five years.
  • Compared with a year earlier, Cash from Operations was higher in four of the last seven quarters, with growth averaging 25.0%.
  • The best year-over-year quarter for Cash from Operations over five years was Q4 2024 (growth of 149.2%); the worst was Q4 2023 (a decline of 78.2%).
  • Per Business Quant data, VRTX's Cash from Operations in the three quarters before Q2 2026 was $1.43 billion (Q1 2026), $498 million (Q4 2025) and $1.24 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 8.62 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 3.44 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 2.87 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 3.57 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 835.00 Mn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn 1.13 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.13 Bn
Mar 31, 2026 1.43 Bn
Dec 31, 2025 498.00 Mn
Sep 30, 2025 1.24 Bn
Jun 30, 2025 1.07 Bn
Mar 31, 2025 818.90 Mn
Dec 31, 2024 584.60 Mn
Sep 30, 2024 1.37 Bn
Jun 30, 2024 -3.75 Bn
Mar 31, 2024 1.31 Bn
Dec 31, 2023 234.60 Mn
Sep 30, 2023 1.27 Bn
Jun 30, 2023 1.13 Bn
Mar 31, 2023 899.90 Mn
Dec 31, 2022 1.08 Bn
Sep 30, 2022 955.50 Mn
Jun 30, 2022 1.14 Bn
Mar 31, 2022 956.20 Mn
Dec 31, 2021 995.00 Mn
Sep 30, 2021 927.20 Mn
API Access

Vertex Pharmaceuticals Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=VRTX&period=max&api_key=YOUR_API_KEY